Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04099134

PACAREG: a Multicenter Registry Trial in Pancreatic Ductal Adencarcinoma

PaCaReg is a multicenter registry trial aiming in the assessement of clinical, epidemiological and biological profiles in patients with pancreatic ductal adenocarcinoma

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pancreas Adenocarcinoma Digestive System Diseases Digestive System Neoplasms Endocrine Gland Neoplasms Endocrine System Diseases Neoplasms Neoplasms by Site Pancreas Cancer Pancreatic Diseases Pancreatic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Treatment naive histologically or cytologically proven pancreatic ductal adenocarcinoma (PDAC) or highly suspicious diagnosis (only pre-curative-intended resection)
  • Age =>18 years
  • written informed consent

Exclusion criteria

  • papillary cancer
  • neuroendocrine pancreatic tumors

Treatment and study plan

Primary outcomes

  1. General assessment of applied therapy modalities in pancreatic cancer

    Time frame: First diagnose to death or end of surveillance (5 years after curative resection)

  2. Quality of life in pancreatic cancer patients

    Time frame: First diagnose to death or end of surveillance (5 years after curative resection)

    EORTC QLQ c30 and PAN 26

Secondary outcomes

  1. General epidemiologic assessment

    Time frame: First diagnose to death or end of surveillance (5 years after curative resection)

    Epidemiologic questionaire

  2. Assessment of tumor surveillance in pancreatic cancer patients

    Time frame: First diagnose to death or end of surveillance (5 years after curative resection)

  3. Evaluation of predictive and prognostic markers

    Time frame: First diagnose to death or end of surveillance (5 years after curative resection)

Study contacts

Contact information is provided by the study sponsor or research team.

Thomas Seufferlein, MD

CONTACT

[email protected]

+49 731 50044501

Sponsors and collaborators

Lead sponsor

University of Ulm

Other

Registry information

Official study title

PaCaReg: A Multicenter Registry Trial for the Assessement of Clinical, Epidemiological and Biological Profiles in Patients With Pancreatic Ductal Adenocarcinoma

Acronym: PaCaReg

Important dates

Study start
2018
Primary completion
2028
Study completion
2029
First posted
Sep 23, 2019
Registry last updated
Sep 25, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.